NY-ESO-1 (product of the CTAG1B gene) is perhaps the best characterised member of this family [137], and may be selectively expressed by cancer stem cells and is expressed in the tumours of approximately 40% of ovarian cancer patients [6]. This evidence concerns the gene CTAG1B and ovarian cancer.